2009 Biological License Application Approvals

This list reflects information regarding the applications as of the approval date. It is not updated with regard to applicant or application status changes. The applications are listed by date of approval.


Note: Approvals are listed with the most recent action at the top.

Tradename/
Proper Name
Indication for Use STN Manufacturer/
License Number
Approval Date
RiaSTAP
Fibrinogen Concentrate (Human)
For the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency (afibrinogenemia and hypofibrinogenemia). 125317/0 CSL Behring GmbH 1/16/2009
 
Updated: January 16, 2009